Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, 12-week Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate Dry Powder 400 mcg Once-daily in Persistent Mild-moderate Asthmatic Patients at Least 12 Years Old

NCT00687531 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00687531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00687531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, 12-week Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate Dry Powder 400 mcg Once-daily in Persistent Mild-moderate Asthmatic Patients at Least 12 Years Old
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2006
Completion date
September 30, 2009
Enrollment
385 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma